Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micuronium chloride vs cisatracurium for pediatric tonsillar adenoidectomy anesthesia
ChiCTR2300075970Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Adenotonsillar hypertrophy (ATH) comparing Micuronium chloride group with Cisatracurium group (2 arms). Primary endpoints: Muscle relaxation aging index and Vital signs. Planned start Oct 2023; status: not yet recruiting.
02
Drugs
mivacuriumcisatracurium
03
Conditions
Adenotonsillar hypertrophy (ATH)
Beyond the preview
Go deeper on ChiCTR2300075970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075970.